Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Yanagi

Showing results (171-180 of 178) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 178 results.
Dermatology (Basel, Switzerland)|January 1, 1997
Inactivation of human viruses by povidone-iodine in comparison with other antisepticsR Kawana, T Kitamura, O Nakagomi, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|July 1, 1997
Importance of intra-abdominal visceral fat accumulation to coronary atherosclerosis in heterozygous familial hypercholesterolaemiaT Nakamura, H Kobayashi, K Yanagi, et al.
European Journal of Pharmacology|September 19, 1996
Synergistic effect of aurintricarboxylic acid and triflavin in a photochemically induced thrombosis model in ratsN Hisamichi, T Kawasaki, K Suzuki, et al.
Nihon Ika Daigaku Zasshi|October 2, 1998
[Removal of bile duct stones by endoscopic papillary balloon dilatation (EPBD) of papilla of Vater]E Uchida, M Onda, T Tajiri, et al.
Atherosclerosis|May 1, 1997
Increased serum remnant lipoproteins in patients with apolipoprotein E7 (apo E Suita)K Yanagi, S Yamashita, H Hiraoka, et al.
Atherosclerosis|July 11, 1997
Characteristics of coronary artery disease and lipoprotein abnormalities in patients with heterozygous familial hypercholesterolemia associated with diabetes mellitus or impaired glucose toleranceK Yanagi, S Yamashita, S Kihara, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 7, 2003
Operating point control system for a continuous flow artificial heart: in vitro studyR Kosaka, K Yanagi, T Sato, et al.
Thrombosis and Haemostasis|April 1, 1996
Antiplatelet and antithrombotic effects of YM337, the Fab fragment of a humanized anti-GPIIb/IIIa monoclonal antibody in monkeysS Kaku, T Kawasaki, N Hisamichi, et al.
Pageof 18

Showing results (171-180 of 178) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 178 results.
Dermatology (Basel, Switzerland)|January 1, 1997
Inactivation of human viruses by povidone-iodine in comparison with other antisepticsR Kawana, T Kitamura, O Nakagomi, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|July 1, 1997
Importance of intra-abdominal visceral fat accumulation to coronary atherosclerosis in heterozygous familial hypercholesterolaemiaT Nakamura, H Kobayashi, K Yanagi, et al.
European Journal of Pharmacology|September 19, 1996
Synergistic effect of aurintricarboxylic acid and triflavin in a photochemically induced thrombosis model in ratsN Hisamichi, T Kawasaki, K Suzuki, et al.
Nihon Ika Daigaku Zasshi|October 2, 1998
[Removal of bile duct stones by endoscopic papillary balloon dilatation (EPBD) of papilla of Vater]E Uchida, M Onda, T Tajiri, et al.
Atherosclerosis|May 1, 1997
Increased serum remnant lipoproteins in patients with apolipoprotein E7 (apo E Suita)K Yanagi, S Yamashita, H Hiraoka, et al.
Atherosclerosis|July 11, 1997
Characteristics of coronary artery disease and lipoprotein abnormalities in patients with heterozygous familial hypercholesterolemia associated with diabetes mellitus or impaired glucose toleranceK Yanagi, S Yamashita, S Kihara, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 7, 2003
Operating point control system for a continuous flow artificial heart: in vitro studyR Kosaka, K Yanagi, T Sato, et al.
Thrombosis and Haemostasis|April 1, 1996
Antiplatelet and antithrombotic effects of YM337, the Fab fragment of a humanized anti-GPIIb/IIIa monoclonal antibody in monkeysS Kaku, T Kawasaki, N Hisamichi, et al.
Pageof 18